Dioxydin®inhibits the pathogens of the ENT infections, including those resistant to antibiotics!

Dioxydin® – is a broad spectrum antibacterial drug, active against the absolute majority of pathogens of outpatient and nosocomial infections.

  • Dioxydin® exhibits the microbiological efficacy of 93%, including the effect on the antibiotic-resistant microorganism strains1
  • No cases of cross-resistance with antibiotics have been described, allowing to use Dioxydin® in cases of polyresistant bacterial flora1
  • Increase in antimicrobial activity in anoxic conditions up to 100 times2


In otorhinolaryngology

  • Acute purulent perforative otitis media
  • Exacerbation of chronic suppurative otitis media
  • Acute tonsillopharyngitis
  • Exacerbation of chronic tonsillitis

In ambulatory surgery

  • Superficial and deep wounds of various location
  • Indolent wounds and trophic ulcers
  • Soft tissue pyogenic cellulitis, infected burns

In hospital surgery

  • Purulent processes in chest and abdomen
  • Purulent pleurisy, pleural empyema, pulmonary abscesses
  • Peritonitis, cystitis
  • Wounds with deep purulent cavities
  • Prevention of infectious complications after bladder catheterization

1 Popov D.A. et al. Dioxydin: Antimicrobial Activity and Prospects of its Clinical Use at Present // Antibiotics and Chemotherapy // 2013, 58; 3-4, pp. 38-43.

2 Е.Н. Padeyskaya E.N. Antibacterial Drug Dioxydin: Particular Biological Activities and Importance in the Treatment of Various Forms of Purulent Infection // 2001, 5, 150-5.

3 Medication Guidelines Dioxydin® (Р N003934/01).